Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 26 | 2022 | 113 | 3.140 |
Why?
|
| Atrial Fibrillation | 25 | 2025 | 410 | 2.340 |
Why?
|
| Atrial Appendage | 6 | 2025 | 24 | 0.940 |
Why?
|
| Pulmonary Veins | 6 | 2021 | 20 | 0.610 |
Why?
|
| Anticoagulants | 5 | 2022 | 122 | 0.590 |
Why?
|
| Thrombosis | 2 | 2025 | 78 | 0.520 |
Why?
|
| Heart Atria | 5 | 2018 | 81 | 0.490 |
Why?
|
| Treatment Outcome | 24 | 2025 | 3408 | 0.480 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2011 | 71 | 0.440 |
Why?
|
| Defibrillators, Implantable | 2 | 2011 | 44 | 0.410 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2011 | 100 | 0.400 |
Why?
|
| Heart Diseases | 3 | 2025 | 114 | 0.340 |
Why?
|
| Preoperative Care | 3 | 2015 | 125 | 0.310 |
Why?
|
| Middle Aged | 25 | 2025 | 11838 | 0.310 |
Why?
|
| Kidney Diseases | 1 | 2011 | 243 | 0.290 |
Why?
|
| Humans | 37 | 2025 | 32271 | 0.280 |
Why?
|
| Postoperative Complications | 5 | 2016 | 818 | 0.270 |
Why?
|
| Aged | 19 | 2025 | 10249 | 0.270 |
Why?
|
| Female | 27 | 2025 | 19943 | 0.260 |
Why?
|
| Thromboembolism | 2 | 2019 | 33 | 0.260 |
Why?
|
| Male | 27 | 2025 | 19437 | 0.260 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 55 | 0.260 |
Why?
|
| Time Factors | 11 | 2019 | 2203 | 0.250 |
Why?
|
| Device Removal | 3 | 2023 | 39 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2022 | 58 | 0.230 |
Why?
|
| Esophageal Fistula | 2 | 2016 | 8 | 0.230 |
Why?
|
| Patient Discharge | 2 | 2023 | 204 | 0.230 |
Why?
|
| Stroke Volume | 3 | 2015 | 417 | 0.220 |
Why?
|
| Thrombectomy | 1 | 2025 | 74 | 0.220 |
Why?
|
| Prospective Studies | 9 | 2020 | 2315 | 0.190 |
Why?
|
| Stroke | 2 | 2019 | 691 | 0.190 |
Why?
|
| Tachycardia, Ventricular | 2 | 2016 | 26 | 0.190 |
Why?
|
| Risk Factors | 10 | 2019 | 3933 | 0.190 |
Why?
|
| Warfarin | 2 | 2015 | 32 | 0.190 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 2238 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2015 | 59 | 0.180 |
Why?
|
| Retrospective Studies | 7 | 2023 | 3609 | 0.180 |
Why?
|
| Esophagus | 2 | 2016 | 29 | 0.180 |
Why?
|
| Hospitalization | 1 | 2023 | 475 | 0.160 |
Why?
|
| Body Surface Potential Mapping | 2 | 2018 | 10 | 0.150 |
Why?
|
| Heart Rate | 2 | 2018 | 364 | 0.140 |
Why?
|
| Vena Cava, Superior | 1 | 2018 | 4 | 0.140 |
Why?
|
| Cohort Studies | 4 | 2021 | 1839 | 0.140 |
Why?
|
| Prevalence | 4 | 2017 | 955 | 0.140 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 230 | 0.140 |
Why?
|
| Electrocardiography | 2 | 2014 | 624 | 0.130 |
Why?
|
| Heart Conduction System | 2 | 2015 | 76 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2017 | 7 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2025 | 309 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 17 | 0.120 |
Why?
|
| Cicatrix | 1 | 2016 | 39 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2016 | 81 | 0.120 |
Why?
|
| Pericardial Effusion | 1 | 2016 | 9 | 0.120 |
Why?
|
| Sinoatrial Node | 1 | 2015 | 4 | 0.120 |
Why?
|
| Tachycardia, Sinus | 1 | 2015 | 5 | 0.120 |
Why?
|
| Recurrence | 4 | 2021 | 286 | 0.110 |
Why?
|
| Balloon Occlusion | 1 | 2016 | 36 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2015 | 65 | 0.110 |
Why?
|
| Survival Rate | 3 | 2015 | 892 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 880 | 0.110 |
Why?
|
| Atrial Flutter | 1 | 2015 | 20 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 132 | 0.110 |
Why?
|
| Amiodarone | 1 | 2014 | 5 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 17 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 77 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 133 | 0.110 |
Why?
|
| International Normalized Ratio | 2 | 2015 | 7 | 0.110 |
Why?
|
| Migraine Disorders | 1 | 2015 | 68 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 56 | 0.100 |
Why?
|
| Comorbidity | 2 | 2016 | 563 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2014 | 413 | 0.100 |
Why?
|
| Heart Failure | 2 | 2011 | 728 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 264 | 0.100 |
Why?
|
| Exercise Test | 1 | 2014 | 218 | 0.100 |
Why?
|
| Incidence | 5 | 2015 | 1242 | 0.100 |
Why?
|
| Adult | 7 | 2015 | 9260 | 0.100 |
Why?
|
| Stents | 1 | 2014 | 159 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 34 | 0.090 |
Why?
|
| United States | 6 | 2019 | 4069 | 0.090 |
Why?
|
| Laser Therapy | 1 | 2013 | 51 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 40 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 854 | 0.090 |
Why?
|
| Equipment Design | 3 | 2021 | 178 | 0.090 |
Why?
|
| Life Style | 1 | 2014 | 394 | 0.090 |
Why?
|
| Quality of Life | 2 | 2015 | 969 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 772 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 1050 | 0.090 |
Why?
|
| Drug Administration Schedule | 3 | 2019 | 276 | 0.090 |
Why?
|
| Sodium Channels | 1 | 2011 | 16 | 0.080 |
Why?
|
| Robotics | 1 | 2012 | 133 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2011 | 146 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 302 | 0.080 |
Why?
|
| Prognosis | 4 | 2016 | 1529 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 3893 | 0.080 |
Why?
|
| Enoxaparin | 1 | 2010 | 13 | 0.080 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 466 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2009 | 13 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2010 | 175 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 152 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 287 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 63 | 0.070 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 322 | 0.070 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 6 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2009 | 476 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1178 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 54 | 0.070 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2018 | 28 | 0.060 |
Why?
|
| Fluoroscopy | 2 | 2017 | 35 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 427 | 0.060 |
Why?
|
| North Carolina | 1 | 2010 | 1300 | 0.060 |
Why?
|
| Body Temperature | 1 | 2006 | 20 | 0.060 |
Why?
|
| Registries | 2 | 2022 | 294 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2016 | 1423 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 77 | 0.060 |
Why?
|
| Texas | 2 | 2016 | 41 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 212 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2021 | 55 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 95 | 0.040 |
Why?
|
| Dobutamine | 1 | 2020 | 54 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2019 | 5 | 0.040 |
Why?
|
| Phrenic Nerve | 1 | 2018 | 5 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 2651 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 47 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2016 | 3 | 0.030 |
Why?
|
| Stethoscopes | 1 | 2016 | 1 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 57 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 94 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 3516 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 40 | 0.030 |
Why?
|
| Premedication | 1 | 2016 | 15 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 190 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 545 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 82 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 124 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 146 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 13 | 0.030 |
Why?
|
| Telemetry | 1 | 2015 | 24 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 49 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2014 | 17 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2014 | 31 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 316 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 212 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 716 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 272 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 554 | 0.020 |
Why?
|
| Reoperation | 1 | 2014 | 247 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2014 | 137 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 821 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1480 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 184 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 40 | 0.020 |
Why?
|
| Heterozygote | 1 | 2011 | 60 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 854 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 250 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2010 | 42 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 329 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2009 | 159 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1159 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 556 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2008 | 197 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 756 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 650 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 312 | 0.020 |
Why?
|
| Child | 1 | 2013 | 2431 | 0.020 |
Why?
|
| Logistic Models | 1 | 2008 | 743 | 0.020 |
Why?
|
| Cryosurgery | 1 | 2006 | 25 | 0.010 |
Why?
|